Tierarztl Prax Ausg K Kleintiere Heimtiere 2023; 51(04): 252-257
DOI: 10.1055/a-2146-6645
Übersichtsartikel

Diagnostischer Nutzen des Anti-Müller-Hormons in der Kleintierpraxis

Diagnostic utility of the anti-Mullerian hormone in companion animals
Beate Walter
1   Chirurgische und Gynäkologische Kleintierklinik, Ludwig-Maximilians-Universität München
› Institutsangaben

Zusammenfassung

Das Anti-Müller-Hormon ist ein Glykoprotein, das bei männlichen Individuen von den Sertolizellen und bei weiblichen von den Granulosazellen sezerniert wird. Bei Hunden und Katzen wurde es erstmals 2011 im Blutserum bestimmt. Inzwischen konnten mehrere Studien die klinischen Anwendungen der Anti-Müller-Hormon-Bestimmung als Parameter in der endokrinen Diagnostik aufzeigen. Dieser Übersichtsartikel fasst den momentanen Wissensstand über die klinischen Anwendungen der Anti-Müller-Hormon-Bestimmung in der Kleintierpraxis zusammen und beschreibt mögliche zukünftige diagnostische Ansätze.

Abstract

The anti-Mullerian hormone is a glycoprotein secreted by Sertoli cells in males and granulosa cells in females. The initial identification of this hormone in canine and feline serum was achieved in 2011. Meanwhile, a variety of studies have demonstrated its clinical significance as a tool in the endocrine diagnosis. This review summarizes the current knowledge about anti-Mullerian hormone in small animal reproduction and describes future opportunities for its diagnostic usage.



Publikationsverlauf

Eingereicht: 15. April 2023

Angenommen: 25. Juli 2023

Artikel online veröffentlicht:
11. Oktober 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Jost A. Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Rec Progr Horm Res 1953; 8: 379-418
  • 2 Claes A, Ball BA, Almeida J. et al. Serum anti-Müllerian hormone concentrations in stallions: Developmental changes, seasonal variation, and differences between intact stallions, cryptorchid stallions, and geldings. Theriogenology. 2013; 79: 1229-1235
  • 3 Lee M, Donahoe P, Hasegawa T. et al. Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. Journal of Clincal Endocrinology and Metabolism 1996; 81: 571-576
  • 4 Rota A, Ballarin C, Vigier B. et al. Age dependent changes in plasma anti-Müllerian hormone concentrations in the bovine male, female, and freemartin from birth to puberty: relationship between testosterone production and influence on sex differentiation. General and Comparative Endocrinology 2002; 129: 39-44
  • 5 Place N, Hansen B, Cheraskin J. et al. Measurement of serum anti-Müllerian hormone concentration in female dogs and cats before and after ovariohysterectomy. Journal of Veterinary Diagnostic Investigation 2011; 23: 524-527
  • 6 Alexander T, Flock U, Reese S. et al. Anti-Mullerian hormone levels in prepubertal dogs and cats. 24th EVSSAR Congress in a Joint Meeting with the 9th Quadrennial International Symposium on Canine and Feline Reproduction. Milan. 2022
  • 7 Flock U, Reese S, Otzdorff C. et al. Anti–Müllerian hormone concentrations in queens throughout the estrous cycle. Domestic Animal Endocrinology 2022; 81: 5
  • 8 Lapuente C, Faya M, Blanco P. et al. Anti-Müllerian hormone in queens: Serum concentrations and total ovarian follicle population. Theriogenology. 2023; 197: 111-115
  • 9 Barbotin AL, Peigné M, Malone SA. et al. Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function. Neuroendocrinology. 2019; 109: 218-219
  • 10 Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002; 124: 601-609
  • 11 Holst BS, Dreimanis U. Anti-Müllerian hormone: a potentially useful biomarker for the diagnosis of canine Sertoli cell tumours. BMC Vet Res 2015; 11: 166-173
  • 12 Walter B, Feulner H, Otzdorff C. et al. Changes in anti-Mullerian hormone concentrations in bitches throughout the oestrous cycle. Theriogenology. 2019; 127: 114-119
  • 13 Axner E, Strom Holst B. Concentrations of anti-Mullerian hormone in the domestic cat. Relation with spay or neuter status and serum estradiol. Theriogenology. 2015; 83: 817-821
  • 14 Bergman D, Larsson A, Hansson-Hamlin H. et al. Prevalence of interfering antibodies in dogs and cats evaluated using a species-independent assay. Veterinary Clinical Pathology 2018; 47: 205-212
  • 15 Bergman D, Larsson A, Hansson-Hamlin H. et al. Investigation of interference from canine anti-mouse antibodies in hormone immunoassays. Veterinary Clinical Pathology 2019; 48: 59-69
  • 16 Snoeck F, Sarrazin S, Wydooghe E. et al. Age and anti-Müllerian hormone levels predict the succsess of in vitro maturation of cat oocytes. Reproduction in Domestic Animals 2017; 52: 98-102
  • 17 Pir Yagci I, Pekcan M, Polat IM. et al. Does serum anti-Müllerian hormone levels always discriminate presence of the ovaries in adult bitches? Comparison of two ELISA kits. Reproduction in Domestic Animals 2016; 51: 910-915
  • 18 Themmen APN, Kalra B, Visser JA. et al. The use of anti-Müllerian hormone as diagnostic for gonadectomy status in dogs. Theriogenology. 2016; 86: 1467-1474
  • 19 Walter B, Coelfen A, Jager K. et al. Anti-Muellerian hormone concentration in bitches with histopathologically diagnosed ovarian tumours and cysts. Reprod Domest Anim 2018; 53: 784-792
  • 20 Flock U, Fischer S, Weeger J. et al. Anti-Müllerian hormone as a diagnostc tool to identify queens with ovarian remnant syndrome. Journal of Feline Medicine and Surgery 2022; 7
  • 21 Böhmer F, Erber K, Ewringmann A. et al. Anti-Müllerian hormone concentrations in female rabbits and its relation to spay status, pseudopregnancy and ovarian follicle numbers. Reproduction in Domestic Animals 2022; 57: 1636-1643
  • 22 Bunck C, Günzel-Apel A-R. Zyklusdiagnostik. In: Günzel-Apel A-R, Bostedt H, editors. Reproduktionsmedizin und Neonatologie von Hund und Katze. Stuttgart: Schattauer; 2016: 35-48
  • 23 Günzel-Apel A-R. Zyklusdiagnostik. In: Günzel-Apel A-R, Bostedt H, editors. Reproduktionsmedizin und Neonatologie von Hund und Katze. Stuttgart: Schattauer; 2016: 413-414
  • 24 Ganz S, Wehrend A. Uptake of exogenous estrogen as a differential diagnosis of ovarian-remnant-syndrome in a bitch: a case report. BMC Vet Res 2021; 17: 225
  • 25 Binder C, Aurich C, Reifinger M. et al. Spontaneous ovulation in cats-Uterine findings and correlations with animal weight and age. Anim Reprod Sci 2019; 209: 106167
  • 26 Axner E, Gustavsson T, Ström Holst B. Estradiol measurement after GnRH-Stimulation as a method to diagnose the presence of ovaries in the female domestic cat. Theriogenology. 2008; 70: 186-191
  • 27 Rholertz M, Ström Holst B, Axner E. Comparison of GnRH-stimulation test and a semiquantative quick test for LH to diagnose presence of ovaries in the female domestic cat. Theriogenology. 2012; 78: 1901-1906
  • 28 Naiman JH, Mayhew PD, Steffey MA. et al. Laparoscopic treatment of ovarian remnant syndrome in dogs and cats: 7 cases (2010-2013). Journal of the American Veterinary Medical Association 2014; 245: 1251-1257
  • 29 Alm H, Holst BS. Identifying ovarian tissuee in the bitch using anti-Müllerian hormone (AMH) or luteinizing hormone (LH). Theriogenology. 2018; 106: 15-20
  • 30 Ball RL, Birchard SJ, May LR. et al. Ovarian remnant syndrome in dogs and cats: 21 cases (2000-2007). J Am Vet Med Assoc 2010; 236: 548-553
  • 31 Little S. Feline Reproduction Problems and clinical challenges. Journal of Feline Medicine and Surgery 2011; 13 508-5-15
  • 32 Rota A, Pregel P, Cannizzo F. et al. Unusual case of uterine stump pyometra in a cat. Journal of Feline Medicine and surgery 2011; 13: 448-450
  • 33 Schoon HA, Beyerbach M, Piechotta M. et al. Klinische Symptomatik, diagnostische Vorgehensweise und Therapie beim so genannten Ovarrest-Syndrom der Hündin. Tierärztliche Praxis Ausgabe K: Kleintiere/Heimtiere 2018; 40: 35-42
  • 34 Wallace MS. The ovarian remnant syndrome in the bitch and queen. Vet Clin North Am Small Anim Pract 1991; 21: 501-507
  • 35 Schlafer DH, Foster RA. Pathology of the genital system. In: Jubb KaPs, editor. Pathology of Domestic Animals. online. Elsevier; 2016: 359-464
  • 36 Miller DM. Ovarian remnant syndrome in dogs and cats: 46 cases (1988-1992). Journal of Veterinary Diagnostic Investigation 1995; 7: 572-574
  • 37 Cellio LM, Degner DA. Testosterone-producing thecoma in a female cat. J Am Anim Hosp Assoc 2000; 36: 323-325
  • 38 Demirel MA, Acar DB. Ovarian remnant syndrome and uterine stump pyometra in three queens. J Feline Med Surg 2012; 14: 913-918
  • 39 Jones SA, Owens SL, Birchard SJ. Hyperandrogenism associated with an ovarian remnant in a spayed female cat. Journal of Feline Medicine and Surgery Open Reports 2019; 1-4
  • 40 Fontes GS, McCarthy RJ. Ovarian remnant syndrome in a cat with ovarian tissue in the omentum. J Am Vet Med Assoc 2020; 257: 631-634
  • 41 DeNardo GA, Becker K, Brown NO. et al. Ovarian remnant syndrome: revascularization of free-floating ovarian tissue in the feline abdominal cavity. J Am Anim Hosp Assoc 2001; 37: 290-296
  • 42 Place N, Cheraskin J, Hansen B. Evaluation of combined assessments of serum anti-Müllerian hormone and progesterone concentrations for the diagnosis of ovarian remnant syndrome in dogs. Journal of the American Veterinary Association 2019; 254: 1067-1072
  • 43 Turna Yilmaz Ö, Toydemir TSF, Kirsan I. et al. Anti-Müllerian hormone as a diagnostic tool for ovarian remnant syndrome bitches. Vet Res Com 2015; 39: 152-162
  • 44 Gozer A, Bahan O, Dogruer G. et al. Serum antimüllerian hormone concentrations in female cats. Relation with ovarian remnant syndrome, ovarian cysts and gonadectomy status. Theriogenology 2023; 200: 106-113
  • 45 MacLachlan NJ. Ovarian disorders in domestic animals. Environmental health perspectives 1987; 73: 27-33
  • 46 Nielson SW, Misdrop W, McEntee K. Tumours of the ovary. Bulletin of the World Health Organisation 1976; 53: 12
  • 47 Johnston SD, Kustritz MV, Olson PNS. Disorders of canine ovary. In: Johnston Sd, Kustritz MV, Olson PNS, editors. Canine and feline theriogenology. Philadelphia: PA: Saunders; 2001: 193-205
  • 48 Rey R, Sabourin J, Venara M. et al. Anti-Müllerian Hormone Is a Specific Marker of Sertoli- and Granulosa-Cell Origin in Gonadal Tumors Hum Pathol 2000; 31
  • 49 Ball BA, Conley AJ, MacLaughlin DT. et al. Expression of anti-Mullerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries. Theriogenology. 2008; 70: 968-977
  • 50 Ball BA, Almeida J, Conley AJ. Determination of serum anti-Mullerian hormone concentrations for the diagnosis of granulosa-cell tumours in mares. Equine Vet J 2013; 45: 199-203
  • 51 Banco B, Veronesi MC, Giudice C. et al. Immunohistochemical evaluation of the expression of anti-Mullerian hormone in mature, immature and neoplastic canine Sertoli cells. J Comp Pathol 2012; 146: 18-23
  • 52 El-Sheikh Ali H, Kitahara G, Nibe K. et al. Plasma anti-Müllerian hormone as a biomarker for bovine granulosa-theca cell tumors: Comparison with immunoreactive inhibin and ovarian steroid concentrations. Theriogenology. 2013; 80: 940-949
  • 53 Gharagozlou F, Youssefi R, Akbarinejad V. et al. Elevated Serum Anti-Müllerian Hormone in an Arabian Mare with Granulosa Cell Tumor. J Equine Vet Sci 2013; 33: 645-648
  • 54 Almeida J, Ball BA, Conley AJ. et al. Biological and clinical significance of anti-Mullerian hormone determination in blood serum of the mare. Theriogenology. 2011; 76: 1393-1403
  • 55 Lane AH, Lee MM, Fuller AF. et al. Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecologic oncology 1999; 73: 51-55
  • 56 Long W-Q, Ranchin V, Pautier P. et al. Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. The Journal of Clinical Endocrinology & Metabolism 2000; 85: 540-544
  • 57 Hayes H, Young JL. Epidemiologic features of canine ovarian neoplasms. Gynecologic Oncology 1978; 6: 348-353
  • 58 Heaps LA, Scudder CJ, Lipscomb VJ. et al. Serum anti-Müllerian hormone concentrations before and after treatment of an ovarian granulosa cell tumour in a cat. JFMS Open Rep 2017; 3
  • 59 Broer S, Dolleman M, Opmeer B. et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Human reproduction update 2011; 17: 46-54
  • 60 Sahmay S, Oncul M, Tuten A. et al. Anti-Müllerian hormone levels as a predictor of the pregnancy rate in women of advanced reproductive age. Journal of Assisted Reproduction and Genetics 2014; 31: 1469-1474
  • 61 Kevenaar ME, Meerasahib MF, Kramer P. et al. Serum Anti-Müllerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice. Endocrinology 2006; 147: 3228-3234
  • 62 Ghanem N, Jin JI, Kim SS. et al. The Anti-Müllerian Hormone Profile is Linked with the In Vitro Embryo Production Capacity and Embryo Viability after Transfer but Cannot Predict Pregnancy Outcome. Reprod Dom Anim 2016; 51: 301-310
  • 63 Guerreiro BM, Batista EO, Vieira LM. et al. Plasma anti-mullerian hormone: an endocrine marker for in vitro embryo production from Bos taurus and Bos indicus donors. Domest Anim Endocrinol 2014; 49: 96-104
  • 64 Rico C, Drouilhet L, Salvetti P. et al. Determination of anti-Müllerian hormone concentrations in blood as a tool to select Holstein donor cows for embryo production: from the laboratory to the farm. Reprod Fertil Dev 2012; 24: 932-944
  • 65 Monniaux D, Barbey S, Rico C. et al. Anti-Müllerian hormone: a predictive marker of embryo production in cattle?. Reprod Fertil Dev 2010; 22: 1083-1091
  • 66 Lahoz B, Alabart J, Monniaux D. et al. Anti-Müllerian hormone plasma concentration in prepubertal ewe lambs as a predictor of their fertility at a young age. BMC Veterinary Research 2012; 8: 118
  • 67 Monniaux D, Baril G, Laine A. et al. Anti-Müllerian hormone as a predictive endocrine marker forembryo production in the goat. Reproduction 2011; 142: 845-854
  • 68 Gharagozlou F, Youssefi R, Akbarinejad V. et al. Low concentration of Anti-Müllerian hormone in Mares with Delayed Uterine Clearance. Journal of Equine Veterinary Science 2014; 34: 575-77.
  • 69 Hollinshead FKC, Walker C, Hanlon DW. Determination of the normal reference interval for anti-Müllerian hormone (AMH) in bitches and use of AMH as a potential predictor of litter size. Reproduction in Domestic Animals 2017; 52: 35-40
  • 70 Chotimanukul S, Goericke-Pesch S, Suwimonteerabutr J. et al. Serum Anti-Müllerian Hormone Levels and Estrous Monitoring of GnRH Agonist Deslorelin-Induced Estrus in Bitches: A Pilot Study. Animals. 2023; 13: 258
  • 71 Carmina E, Campagna AM, Fruzzetti F. et al. AMH Measurement Versus Ovarian Ultrasound in the Diagnosis of Polycystic Ovary Syndrome in Different Phenotypes. Endocr Pract 2016; 22: 287-293
  • 72 Faya M, Marchetti C, Priotto M. et al. Postponement of canine puberty by neonatal administration of a long term release GnRH superagonist. Theriogenology. 2018; 118: 190-195
  • 73 Faya M, Marchetti C, Priotto M. et al. Anti-Müllerian hormone of non-pubertal adult dogs treated neonatally with a GnRH agonist. 21st EVSSAR congress 2018; 160
  • 74 Ferré-Dolcet L, Ferro S, Contiero B. et al. Resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queens. Reproduction in Domestic Animals 2022; 57: 3-9
  • 75 Leykam C, Otzdorff C, Flock U. et al. Anti-Müllerian hormone concentration in dogs with unilateral cryptrochidism. Reproduction in Domestic Animals 2018; 53: 20
  • 76 Walter B, Flock U, Leykam C. et al. Serum anti-Mullerian hormone concentration as a diagnostic tool to identify testicular tissue in canine disorders of sexual development. Domest Anim Endocrinol 2022; 78: 106654
  • 77 Romagnoli SE. Canine cryptorchidism. The Veterinary clinics of North America Small animal practice 1991; 21: 533-544
  • 78 Olson PN, Mulnix JA, Nett TM. Concentrations of luteinizing hormone and follicle-stimulating hormone in the serum of sexually intact and neutered dogs. American journal of veterinary research 1992; 53: 762-766
  • 79 Felumlee AE, Reichle JK, Hecht S. et al. Use of ultrasound to locate retained testes in dogs and cats. Vet Radiol Ultrasound 2012; 53: 581-585
  • 80 Veronesi M, Riccardi E, Rota A. et al. Characteristics of cryptic/ectopic and contralateral scrotal testes in dogs between 1 and 2 years of age. Theriogenology. 2009; 72: 969-977
  • 81 Horňáková L, Vrbovska T, Pavl’ak M. et al. The evaluation of blood concentrations of testosterone, 17β-oestradiol and anti-Müllerian hormone in dogs with cryptorchidism and testicular tumours. Polish. Journal of Veterinary Science 2017; 20: 677-685
  • 82 Purswell BJ, Wilcke JR. Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone. J Reprod Fertil Suppl 1993; 47: 335-341
  • 83 Leykam C, Flock U, Otzdorff C. et al. Anti-Muellerian hormone as a diagnostic tool for monorchidism in dogs – a case report. First Symposium of the European College for Animal Reproduction (ECAR). Vienna. 2019
  • 84 Hayes HM, Pendergrass TW. Canine testicular tumors: epidemiologic features of 410 dogs. International Journal of Cancer 1976; 18: 482-487
  • 85 Ortega-Pacheco A, Rodríguez-Buenfil J, Segura-Correa J. et al. Pathological conditions of the reproductive organs of male stray dogs in the tropics: prevalence, risk factors, morphological findings and testosterone concentrations. Reproduction in domestic animals 2006; 41: 429-437
  • 86 Liao AT, Chu P-Y, Yeh L-S. et al. A 12-Year Retrospective Study of Canine Testicular Tumors. Journal of Veterinary Medical Science 2009; 71: 919-923
  • 87 Russo M, England GCW, Catone G. et al. Imaging of Canine Neoplastic Reproductive Disorders. Animals. 2021; 11: 1213
  • 88 Günzel-Apel A-R. Organerkrankungen: Hoden und Nebenhoden. In: Günzel-Apel A-R, Bostedt H, editors. Reproduktionsmedizin und Neonatologie von Hund und Katze. Stuttgart: Schattauer; 2016: 661-676
  • 89 Mischke R, Meurer D, Hoppen HO. et al. Blood plasma concentrations of oestradiol-17β, testosterone and testosterone/oestradiol ratio in dogs with neoplastic and degenerative testicular diseases. Research in Veterinary Science 2002; 73: 267-272
  • 90 Ano H, Hidaka Y, Katamoto H. Evaluation of anti-Müllerian hormone in a dog with a Sertoli ccell tumour. Vet Dermatol 2014; 25: 142
  • 91 Domain G, Buczkowska J, Kalak P. et al. Serum Anti-Müllerian Hormone: A Potential Semen Quality Biomarker in Stud Dogs?. Animals. 2022; 12: 323
  • 92 Giudice C, Banco B, Veronesi MC. et al. Immunohistochemical expression of markers of immaturity in sertoli and seminal cells in canine testicular atrophy. J Comp Pathol 2014; 150: 208-215
  • 93 Balogh O, Somoskoi B, Kollar E. et al. Anti-Mullerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog. Theriogenology. 2021; 175: 100-10.
  • 94 Otzdorff C, Aupperla-Lellbach H, Walter B. High anti-Müllerian hormone concentration in a dog with testicular degeneration 24th EVSSAR Congress in a Joint Meeting with the 9th Quadrennial International Symposium on Canine and Feline Reproduction. Milan. 2022
  • 95 Meyers-Wallen VN. Gonadal and sex differentiationabnormalities of dogs and cats. Sexual Development 2012; 6: 46-60
  • 96 Poth T, Breuer W, Walter B. et al. Disorders of sex development in the dog – Adoption of a new nomenclature and reclassification of reproted cases. Animal Reproduction Science 2010; 121: 197-207
  • 97 O’Connor CL, Schweizer C, Gradil C. et al. Trisomy-X with estrous cycle anomalies in two female dogs. Theriogenology. 2011; 76: 374-380
  • 98 Khan FA, Gartley CJ, Khanam A. Canine cryptorchidism: An update. Reproduction in Domestic Animals 2018; 53: 1263-70.
  • 99 Buijtels JJ, de Gier J, Kooistra HS. et al. Disorders of sexual development and associated changes in the pituitary-gonadal axis in dogs. Theriogenology. 2012; 78: 1618-1626
  • 100 Buijtels JJ, de Gier J, van Haeften T. et al. Minimal external masculinization in a SRY-negative XX male Podenco dog. Reprod Domest Anim 2009; 44: 751-756
  • 101 Perez-Gutierrez JF, Monteagudo LV, Rodriguez-Bertos A. et al. Bilateral Ovotestes in a 78, XX SRY-Negative Beagle Dog. Journal of the American Animal Hospital Association 2015; 51: 267-271
  • 102 Meyers-Wallen VN, Mac Laughlin D, Palmer V. et al. Müllerian inhibiting substance secretion is delayed in XX sex reversed dog embryos. Mol Reprod Dev 1994; 39: 1-7
  • 103 Dierks C, Distl O. Kongenitale Fehlbildungen des Reproduktionstraktes. In: Günzel-Apel A-R, Bostedt H, editors. Reproduktionsmedizin und Neonatologie von Hund und Katze. 1 ed. Stuttgart: Schattauer; 2016: 158-169
  • 104 Meyers-Wallen VN, Schlafer D, Barr I. et al. Sry-negative XX sex reversal in purebred dogs. Journal of Molecular Reproductin and Development 1999; 53: 266-273